Sistemik Lupus Eritematozus ve Hemşirelik Yönetimi

Bu derleme makalede amaç, sistemik lupus eritematozus (SLE) hastalarında sık görülen hemşirelik tanılarının yönetimine ilişkin bilgi sağlamaktır. SLE, cildi, eklemleri, mukozayı, kalbi, akciğerleri, böbrekleri ve sinir sistemini etkileyebilen multisistemik otoimmün bir hastalıktır. SLE’nin seyri alevlenme ve remisyon dönemleri ile karakterizedir. Hastalığın tedavisinde semptomların kontrol altına alınması ve organların zarar görme riskini azaltmaya yönelik ilaç rejimleri kullanılır. Hastalık ve tedaviye bağlı yaşanılan günlük aktivitelerdeki bozulma, iş ve gelir kaybı yaşam kalitesini olumsuz yönde etkilemektedir. Hastalarda, ağrı, yorgunluk, kutanöz ve eklem bulguları ile uyku örüntüsünde bozulma, beden görünümünde değişiklik, anksiyete ve bilgi eksikliği hemşirelik tanılarına sıklıkla rastlanılmaktadır. Bu hemşirelik tanılarının yönetiminde egzersiz, bilişsel-davranışsal terapi, masaj gibi bağımsız hemşirelik girişimlerinin yanı sıra hemşireler tarafından verilen danışmanlık ve terapötik eğitimle hastalığa uyumun artırılması, hastaların güçlendirilmesi hedeflenmelidir.

Systemic Lupus Erythematosus and Nursing Management

The aim of this review article is to provide information in the management of common nursing diagnoses in systemic lupus erythematosus (SLE) patients. SLE is a multisystemic autoimmune disease that can affect the skin, joints, mucosa, heart, lungs, kidneys and nervous system. The course of SLE is characterized by episodes of exacerbation and remission. In treatment of SLE, drug regimens is used to control the symptoms of the disease and reduce the risk of organ damage. Caused by disease and treatment, disruption in daily activities, loss of work and income may adversely affect the quality of life of patients. Pain, fatigue, cutaneous and joint symptoms and nursing diagnoses such as sleep pattern deterioration, changes in body appearance, anxiety and lack of information are frequently encountered among patients. In the management of these nursing diagnoses, it should be aimed to increase adherence of disease and to empower patients by counseling and training given by nurses as well as independent nursing interventions such as exercise, cognitive-behavioral therapy and massage.

PDF

___

1. Arthritis Society. Systemic lupus erythematosus. Last updated September, 2017. Available from: https://arthritis.ca/aboutarthritis/arthritis-types-(a-z)/types/systemic-lupuserythematosus, 14.02.2019.
2. Crow MK. Systemic lupus erythematosus and related syndromes. In: Kelley&Firestein’s Textbook of Rheumatology, 10th ed., Philadelphia: Elsevier, 2017: 1329-1344.
3. Rao V, Ramsey-Goldman R, Gordon C. Systemic lupus erythematosus and lupus-like sysndromes. In: ABC of Rheumatology. Adebajo A, Dunkley L (editors), Rheumatology. 5th ed., Hoboken: John Wiley & Sons Ltd., 2018: 107-113.
4. Parlar Kılıç S. Eklem ve bağ dokusu hastalıkları. İçinde, Temel İç Hastalıkları Hemşireliği Ve Farklı Boyutları İle Kronik Hastalıklar (eds Ovayolu N, Ovayolu Ö). Adana: Çukurova Nobel Tıp Kitabevi, 2017: 253-256.
5. Ahn GE, Ramsey-Goldman R. Fatigue in systemic lupus erythematosus. Int J Clin Rheumatol, 2012; 7(2): 217-227.
6. Dima A, Caraiola S, Delcea C, & et al.Selfreported disease severity in women with systemic lupus erythematosus. Rheumatol Int, 2018; 39(3): 533-539. doi: 10.1007/s002T96-018-4203-1.
7. Magro R, Borg AA. Characterisation of patients with systemic lupus erythematosus in Malta: A population based cohort cross-sectional study. Biomed Res Int, 2018: 1-7 https://doi.org/10.1155/2018/2385386
8. Du X, Zhao Q, Zhuang Y, Chen H, & et al. Fatigue of systemic lupus erythematosus in China:contributors and effects on the quality of life. Patient Prefer Adherence, 2018; 6(12): 1729-1735
9. Booth S, Price E, Walker E. Fluctation, invisibilty, fatigue-the barriers to maintaining employment with systemic lupus erythematosus: results of an online survey. Lupus, 2018;27(14): 2284-2291.
10.Wilkinson JM, Barcus L. Pearson hemşirelik tanıları el kitabı. Kapucu S, Akyar I, Korkmaz F (Çev. Editörleri). Ankara: Pelikan Yayınevi, 2018;ss.274-279,599-604, 937-942.
11.American College of Rheumatology. Obesity linked with depressive symptoms and increased activity in women with lupus. Updated November 4, 2017. https://www.rheumatology.org/AboutUs/Newsroom/Press Releases/ArticleType/ArticleView/ArticleID/847.
12.American College of Rheumatology. Omega-3 and omega-6 fatty acid intak emay affect lupus outcomes. Available from, https://www.rheumatology.org/AboutUs/Newsroom/PressReleases/ArticleType/ArticleView/ArticleID/832, 22.11.2018.
13.Tench CM, McCarthy J, McCurdie I, & et al. Fatigue in systemic lupus erytematosus: a randomized controlled trial of exercise. Rheumatology, 2003, 42(9): 1050-1054.
14.Lupus UK. Fatigue. 2015. Available from https://www.lupusuk.org.uk/fatigue/ 14.12.2018.
15.Yancey JR, Thomas SM. Chronic fatigue syndrome: diagnosis and treatment. AFP, 2012; 86(8): 741-746.
16.O’Riordan R, Doran M, Connolly D. Fatigue and activity management education for individuals with systemic lupus erythematosus. OTI, 2017; Jan 11: 1-12. https://doi.org/10.1155/2017/4530104
17.Howard P. March’s topic of the month-Pain management. April 4, 2017. Available from, https://www.M.org.uk/painmanagement/14.12.2018.
18.İnan Ç, Kıyak E. Diz osteoartritli hastalarda sıcak ve soğuk uygulamanın ağrı, tutukluluk ve fiziksel fonksiyon üzerine etkisi. Hemşirelikte Araştırma ve Geliştirme Dergisi, 2014; 16(2): 1-10.
19.Açıksoz S, Akyuz A, Tunay S. The effect of self-administered superficial local hot and cold application methods on pain, functional status and quality of life in primary knee osteoarthritis patients. J Clin Nurs, 2017; 26(23-24): 5179-5190.
20.Arthritis Research UK. Therapy occupational therapy and arthritis. 2014. file:///C:/Users/user/Downloads/2255%20Occupati onal%20Therapy%2014-1.pdf
21.https://www.arthritis.org/living-witharthritis/treatments/natural/other-therapies/heatcold-pain-relief.php, https://www.arthritis.org.au/arthritis/arthritisinsights/tips-for-using-hot-and-cold-therapies/
22.Zhang J, Wei W, Wang CM. Effects of psychological interventions for patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus, 2012; 21(10): 1077–87.
23.Conceição CTM, Meinão IM, Bobmbana JA, & et al. Psychoanalytic psychotherapy improves quality of life, depresssion, anxiety and coping in patients with systemic lupus erythematosus: a controlled randomized clinical trial. Adv Rheumatol, 2019; 59(4): 1-10.
24.Farhat MM, Condette-Wojtasik G, Maillard H, & et al. Exploring illness perceptions of lupus patients for a motivational environment in therapeutic education. Rev Med Interne, 2019; 40(8): 501-507 doi: 10.1016/j.revmed.2018.11.002
25.Karlson EW, Liang MH, Eaton H, & et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum, 2004; 50(6): 1832- 1841.
26.Zhang X, Tıan Y, Lı J, & et al.Effect of targeted nursing applied to SLE patients. Exp Ther Med, 2016; 11: 2209-2212.
27.Jolly M, Pickard AS, Mikolaitis RA, & et al. Body image in patients with systemic lupus erythematosus. Int J Behav Med, 2012;19(2): 157- 164.
28.Zhao Q, Cui Y, Li L, & et al. An analysis of the factors influencing the body image disturbance with systemic lupus erythematosus living in China. Ann Rheum Dis., 2017; 76(Suppl 2): 1234.
29.Hassett AL, Radvanski DC, Hale E. A qualitative study of self-image and body image in individuals with systemic lupus erythematosusACR/ARHP Annual Meeting, 2012 Abstract number 2425. https://acrabstracts.org/abstract/a-qualitative-studyof-self-image-and-body-image-in-individuals-withsystemic-lupus-erythematosus/
30.Fingeret MC, Teo I, Epner DE. Managing body image difficulties of adult cancer patients. cancer, 2014; 120: 633-41.
31.Young KA, Munroe ME, Harley JB, Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erytematosus. Lupus, 2018; 27(9): 1524-1531.
32.Bani Younis M, Hayajneh F, Batiha AM. Measurement and nonpharmacologic management of sleep disturbance in the intensive care units: A literature review. Crit Care Nurs Q, 2019; 42(1): 75- 80.
33.Bulechek GM, Butcher HK, Dochterman JM, & et al. Hemşirelik Girişimleri Sınıflaması (NIC). Erdemir F, Kav S, Akman Yılmaz A (Çev. Ed.). 6. Baskı, İstanbul: Nobel Tıp Kitabevi, 2017.
34.Unterman, A., Nolte, J. E., Boaz, M., & et al.Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. In Semin Arthritis Rheum, 2011; 41(1): 1-11.
35.Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., & et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis, 2010; 69(12): 2074-2082.
36.Scottish Intercollegiate Guidelines Network (SIGN). Risk reduction and management of delirium. A national clinical guideline Edinburgh: SIGN; 2019. Available from URL: http://www.sign.ac.uk , 10.05.2019.
37.Wallace D. Weisman M.H. Clinical features of systemic lupus erythematosus. In Hochberg MC, Gravallese EM, Sılman AJ, Smolen JS, Weinblatt ME, Weisman MH (editors), Rheumatology. Elsevier, Philadelphia, 7th edition, 2019: 1103-1115.
38.Yavuz Ş. Sistemik Lupus Eritematozus. T. Kaşifoğlu, U. Kalyoncu, C. Çalışır (ed) Romatoloji Atlası, İstanbul: Adare İnternational Ltd. Şti. 2015: 78-90.
39.Yılmaz S. Sistemik Lupus Eritematozus. F.İ. Çınar, M. Çınar, S. Yılmaz, & H. Erdem (Ed.), Romatoloji Hemşireliği ve Klinik Uygulamalar içinde, İstanbul: Deomed, .2016: 103-108.
40.Wheeler, T. Systemic lupus erythematosus: the basics of nursing care. BJN, 2010; 19 (4): 249-253.
41.National Institutes of Health (NIH), National Institutes of Arthritis and Musculoskeletal and Skin Diseases. Lupus : a patient care guide for nurses and other health professionals. 3rd ed. (Internet). Bethesda, MD: The Institute; 2006. Available from: http://www.aaaceus.com/courses/NL0210_article1. pdf , 10.05.2019.
42.Mok C.C. Gastrointestinal, hepatic, and pancreatic disorders in systemic lupus erythematosus. In G. Tsoukas, Systemic Lupus Erythematosus Basic, Applied and Clinical Aspects, USA: Elsevier, 2016; p. 391-401.
43.Khatibi M, Shakoorpour A.H., Jahromi Z.M., and Ahmadzadeh Z. Te prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus. Lupus, 2012; 21(12): 312–1315.
44.Correa, J. D., & et al. Impact of systemic lupus erythematosus on oral health-related quality of life. Lupus, 2018; 27(2): 283-289.
45.Quinn B, Thompson, M, Treleaven, J & et al. United Kingdom Oral Care in Cancer Guidance: Second Edition, 2015. Available from: www.ukomic.co.uk , 10.05.2019
46.European Oral Care in Cancer Group (EOCC). Oral Care Guidance and Support. 2017. Available from, https://www.cancernurse.eu/documents/EOCCGuid elinesv7.pdf ,10.05.2019
47.Peterson DE, Boers-Doets CB, Bensadoun RJ & et al. on behalf of the ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol, 2015; 26 (Supplement 5): 139–151.